Sensyne Health plc (LON: SENS) has entered a pact with Somerset NHS Foundation Trust and has signed a five-year non-exclusive Strategic Research Agreement (SRA).
- As per the agreement entered by the two, Somerset will be getting 1,428,571 ordinary shares in Sensyne Health plc representing 1.11 per cent of the existing issued share capital of the company.
- The agreement is expected to provide an ethical application of clinical AI research to enhance patient care and fast-track research into new medicines.
- Somerset NHS Foundation Trust with a dataset covering 1.1 million unique patient records, is the first NHS trust to provide community, mental health, and acute hospital services.
- On 16 November 2020, the stocks of the company improved by 1.26% from its previous closing, hovering at around GBX 120.50 at 09:59 AM GMT+1.